230 related articles for article (PubMed ID: 22560927)
1. The potential role of racecadotril in the treatment of diarrhea associated with roflumilast.
López-Campos JL; Gutiérrez C; Calero C
Arch Bronconeumol; 2012 Nov; 48(11):426. PubMed ID: 22560927
[No Abstract] [Full Text] [Related]
2. Roflumilast (Daliresp) for COPD.
Med Lett Drugs Ther; 2011 Jul; 53(1369):59-60. PubMed ID: 21778965
[No Abstract] [Full Text] [Related]
3. Roflumilast for chronic obstructive pulmonary disease.
Eller P; Pechlaner C
Lancet; 2005 Nov; 366(9500):1845-6; author reply 1846-7. PubMed ID: 16310543
[No Abstract] [Full Text] [Related]
4. The divergent opinions of regulatory authorities on roflumilast are puzzling but we need new drugs for treating chronic obstructive pulmonary disease.
Cazzola M
Ther Adv Respir Dis; 2010 Aug; 4(4):195-8. PubMed ID: 20696819
[No Abstract] [Full Text] [Related]
5. Roflumilast for severe COPD?
Drug Ther Bull; 2011 Apr; 49(4):45-8; quiz iii-iv. PubMed ID: 21467576
[TBL] [Abstract][Full Text] [Related]
6. [Roflumilast: a new approach to therapy of chronic obstructive pulmonary disease].
Kreutzkamp B
Med Monatsschr Pharm; 2010 Jul; 33(7):236-43. PubMed ID: 20687460
[TBL] [Abstract][Full Text] [Related]
7. What is the role of roflumilast in chronic obstructive pulmonary disease?
Lau C; Mehta AC; Hatipoglu U
Cleve Clin J Med; 2017 Jan; 84(1):13-15. PubMed ID: 28084977
[No Abstract] [Full Text] [Related]
8. Roflumilast, indacaterol maleate, and abiraterone acetate.
Hussar DA; DePasquale J
J Am Pharm Assoc (2003); 2011; 51(5):668-71. PubMed ID: 21896467
[No Abstract] [Full Text] [Related]
9. The potential role of roflumilast: the new phosphodiesterase-4 inhibitor.
Karish SB; Gagnon JM
Ann Pharmacother; 2006 Jun; 40(6):1096-104. PubMed ID: 16735669
[TBL] [Abstract][Full Text] [Related]
10. Roflumilast for asthma and chronic obstructive pulmonary disease.
Cowan C
Issues Emerg Health Technol; 2005 Oct; (74):1-4. PubMed ID: 16317827
[TBL] [Abstract][Full Text] [Related]
11. [COPD and diabetes mellitus. Does pulmonary medication modify blood glucose metabolism?].
MMW Fortschr Med; 2011 Mar; 153(11):17. PubMed ID: 22165624
[No Abstract] [Full Text] [Related]
12. Reduce disease burden and improve lung function-roflumilast: approved for moderate to severe COPD: update for the clinical nurse specialist.
O'Malley P
Clin Nurse Spec; 2011; 25(4):176-7. PubMed ID: 21654371
[No Abstract] [Full Text] [Related]
13. Racecadotril-is there enough evidence to recommend it for treatment of acute diarrhea?
Bhan MK; Bhatnagar S
Indian Pediatr; 2004 Dec; 41(12):1203-4. PubMed ID: 15623899
[No Abstract] [Full Text] [Related]
14. [Intractable diarrhoea and severe weight loss by roflumilast].
Horna O; Toyas C
Med Clin (Barc); 2013 Aug; 141(3):116-8. PubMed ID: 23768858
[TBL] [Abstract][Full Text] [Related]
15. Roflumilast for the treatment of chronic obstructive pulmonary disease.
Antoniu SA
Curr Opin Investig Drugs; 2006 May; 7(5):412-7. PubMed ID: 16729716
[TBL] [Abstract][Full Text] [Related]
16. Roflumilast added to triple therapy in patients with severe COPD: a real life study.
Muñoz-Esquerre M; Diez-Ferrer M; Montón C; Pomares X; López-Sánchez M; Huertas D; Manresa F; Dorca J; Santos S
Pulm Pharmacol Ther; 2015 Feb; 30():16-21. PubMed ID: 25445930
[TBL] [Abstract][Full Text] [Related]
17. Roflumilast: a novel treatment for chronic obstructive pulmonary disease.
Reid DJ; Pham NT
Ann Pharmacother; 2012 Apr; 46(4):521-9. PubMed ID: 22433610
[TBL] [Abstract][Full Text] [Related]
18. Roflumilast for the treatment of chronic obstructive pulmonary disease.
Rabe KF
Expert Rev Respir Med; 2010 Oct; 4(5):543-55. PubMed ID: 20649375
[TBL] [Abstract][Full Text] [Related]
19. [Phosphodiesterase-4 inhibitors: roflumilast].
Izquierdo Alonso JL
Rev Clin Esp; 2011 Mar; 211 Suppl 2():22-30. PubMed ID: 21596170
[TBL] [Abstract][Full Text] [Related]
20. Clinical Considerations for Roflumilast: A New Treatment for COPD.
Kelly Freeman ML
Consult Pharm; 2012 Mar; 27(3):189-93. PubMed ID: 22421519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
